OBJECTIVE: Preliminary test of a manualized, measurement-guided treatment for depression for adolescents and young adults in care at 4 sites of the Adolescent Trials Network for HIV/AIDS Interventions. DESIGN: The US sites were randomly assigned to either a 24-week, combination cognitive behavioral therapy and medication management algorithm (COMB) tailored for youth living with HIV (YLWH) or to treatment as usual (TAU). METHODS: Youth at TAU sites had access to therapists and medication management as needed. COMB-site clinicians were trained in the manualized intervention and participated in supervision calls to monitor intervention fidelity. RESULTS: Over the course of the study with 44 participants, those in COMB, compared with those in TAU, reported fewer depressive symptoms, P < 0.01 (as measured by the Quick Inventory for Depression symptoms) and were more likely to be in remission, P < 0.001 (65% vs. 10% at week 24, end of treatment, and 71% vs. 7% at week 48, final follow-up). A greater proportion of COMB participants received psychotherapy (95% vs. 45%, P < 0.001) and attended more sessions (12.6 vs. 5, P < 0.001) than those in TAU. Viral load decreased in both groups and was associated (P < 0.05) with reduction in depressive symptoms. CONCLUSIONS: A 24-week manualized, measurement-guided psychotherapy and medication management algorithm tailored for YLWH was more effective in achieving and sustaining remission from depression than TAU at HIV care clinic sites. Given observed treatment efficacy, this structured combination treatment could be disseminated to medical clinics to successfully treat YLWH, who are at particular risk for depression.
RCT Entities:
OBJECTIVE: Preliminary test of a manualized, measurement-guided treatment for depression for adolescents and young adults in care at 4 sites of the Adolescent Trials Network for HIV/AIDS Interventions. DESIGN: The US sites were randomly assigned to either a 24-week, combination cognitive behavioral therapy and medication management algorithm (COMB) tailored for youth living with HIV (YLWH) or to treatment as usual (TAU). METHODS: Youth at TAU sites had access to therapists and medication management as needed. COMB-site clinicians were trained in the manualized intervention and participated in supervision calls to monitor intervention fidelity. RESULTS: Over the course of the study with 44 participants, those in COMB, compared with those in TAU, reported fewer depressive symptoms, P < 0.01 (as measured by the Quick Inventory for Depression symptoms) and were more likely to be in remission, P < 0.001 (65% vs. 10% at week 24, end of treatment, and 71% vs. 7% at week 48, final follow-up). A greater proportion of COMB participants received psychotherapy (95% vs. 45%, P < 0.001) and attended more sessions (12.6 vs. 5, P < 0.001) than those in TAU. Viral load decreased in both groups and was associated (P < 0.05) with reduction in depressive symptoms. CONCLUSIONS: A 24-week manualized, measurement-guided psychotherapy and medication management algorithm tailored for YLWH was more effective in achieving and sustaining remission from depression than TAU at HIV care clinic sites. Given observed treatment efficacy, this structured combination treatment could be disseminated to medical clinics to successfully treat YLWH, who are at particular risk for depression.
Authors: A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan W Stewart; Diane Warden; George Niederehe; Michael E Thase; Philip W Lavori; Barry D Lebowitz; Patrick J McGrath; Jerrold F Rosenbaum; Harold A Sackeim; David J Kupfer; James Luther; Maurizio Fava Journal: Am J Psychiatry Date: 2006-11 Impact factor: 18.112
Authors: Heidi K Moore; Carroll W Hughes; James C Mundt; A John Rush; Laurie Macleod; Graham J Emslie; Shailesh Jain; Dayna S Geralts; Ira H Bernstein; Joseph P Horrigan; Madhukar H Trivedi; John H Greist Journal: J Clin Psychiatry Date: 2007-09 Impact factor: 4.384
Authors: Amy H Cheung; Rachel A Zuckerbrot; Peter S Jensen; Kareem Ghalib; Danielle Laraque; Ruth E K Stein Journal: Pediatrics Date: 2007-11 Impact factor: 7.124
Authors: Boris Birmaher; David Brent; William Bernet; Oscar Bukstein; Heather Walter; R Scott Benson; Allan Chrisman; Tiffany Farchione; Laurence Greenhill; John Hamilton; Helene Keable; Joan Kinlan; Ulrich Schoettle; Saundra Stock; Kristin Kroeger Ptakowski; Jennifer Medicus Journal: J Am Acad Child Adolesc Psychiatry Date: 2007-11 Impact factor: 8.829
Authors: Laura B Whiteley; Elizabeth M Olsen; Kayla K Haubrick; Enyonam Odoom; Nicholas Tarantino; Larry K Brown Journal: Curr HIV/AIDS Rep Date: 2021-06-21 Impact factor: 5.071
Authors: Larry K Brown; Miriam Chernoff; Betsy D Kennard; Graham J Emslie; Kathryn Lypen; Sarah Buisson; Adriana Weinberg; Laura B Whiteley; Shirley Traite; Chelsea Krotje; Lauren Harriff; Ellen Townley; Amber Bunch; Murli Purswani; Ray Shaw; Stephen A Spector; Allison Agwu; David E Shapiro Journal: J Acquir Immune Defic Syndr Date: 2021-12-15 Impact factor: 3.771
Authors: Hiran Thabrew; Karolina Stasiak; Sarah E Hetrick; Liesje Donkin; Jessica H Huss; April Highlander; Stephen Wong; Sally N Merry Journal: Cochrane Database Syst Rev Date: 2018-12-22
Authors: Ingrid Eshun-Wilson; Nandi Siegfried; Dickens H Akena; Dan J Stein; Ekwaro A Obuku; John A Joska Journal: Cochrane Database Syst Rev Date: 2018-01-22
Authors: Andreas D Haas; Cordelia Kunzekwenyika; Stefanie Hossmann; Josphat Manzero; Janneke van Dijk; Ronald Manhibi; Ruth Verhey; Andreas Limacher; Per M von Groote; Ethel Manda; Michael A Hobbins; Dixon Chibanda; Matthias Egger Journal: BMJ Open Date: 2021-07-07 Impact factor: 2.692
Authors: Dorothy E Dow; Blandina T Mmbaga; John A Gallis; Elizabeth L Turner; Monica Gandhi; Coleen K Cunningham; Karen E O'Donnell Journal: BMC Public Health Date: 2020-09-04 Impact factor: 4.135
Authors: Christina A Laurenzi; Stefani du Toit; Wole Ameyan; G J Melendez-Torres; Tashmira Kara; Amanda Brand; Yeukai Chideya; Nina Abrahams; Melissa Bradshaw; Daniel T Page; Nathan Ford; Nadia A Sam-Agudu; Daniella Mark; Marco Vitoria; Martina Penazzato; Nicola Willis; Alice Armstrong; Sarah Skeen Journal: J Int AIDS Soc Date: 2021-08 Impact factor: 6.707